Therefore, understanding the molecular characteristics of HER2-positive gastric cancer provides highly significant and crucial insights for future therapeutic development [ 9 – 12 ].
← all excerpts
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer.
1
—
—